Trials / Completed
CompletedNCT00521170
Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.
Randomized, Monocenter, Double Blind, Placebo-controlled, Single Oral Dose, Three-way Cross Over Study, to Compare Levocetirizine and Desloratadine on Allergen-induced Wheal and Flare Reaction During 24 Hours in 18 Adult Allergic Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- —
Summary
Compare the activity of 5 mg levocetirizine and 5 mg desloratadine on allergen-induced wheal and flare reaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2005-01-01
- Completion
- 2005-01-01
- First posted
- 2007-08-27
- Last updated
- 2013-12-16
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00521170. Inclusion in this directory is not an endorsement.